TITLE:
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes

CONDITION:
Diabetes

INTERVENTION:
biphasic insulin aspart

SUMMARY:

      This trial is conducted in the United States of America (USA). The purpose of this study is
      to test whether Biphasic Insulin Aspart 70/30 twice a day with Metformin improves glycemic
      control vs. once daily Insulin Glargine with Metformin in subjects with Type 2 Diabetes who
      are inadequately controlled on basal insulin plus oral anti-diabetic therapy.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Type 2 Diabetes
      
